HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR To Consider Re-Review Of Parabens Following Europe’s New Guidance

This article was originally published in The Rose Sheet

Executive Summary

Following Denmark’s decision to ban parabens in children’s cosmetics and the EC Scientific Committee on Consumer Safety’s recently revised opinion for parabens acknowledging a possible risk in diaper products for children under 6 months of age, the Cosmetic Ingredient Review Expert Panel may consider re-reviewing the ingredient group.

You may also be interested in...



CIR Recalculates Parabens Safety Margins; Will Expert Panel’s Confidence Be Shaken?

The Cosmetic Ingredient Review’s newly figured margins of safety for single- and multi-paraben use in cosmetic products are dramatically lower than previous MOSs that informed the Expert Panel’s 2008 “safe as used” conclusions. Whether the panel still deems the MOSs sufficiently protective is the question going into the group’s Sept. 24-25 meeting.

Europe Bans Preservative Mixture MCI/MI In Leave-On Cosmetics

By July 16, 2015, cosmetics manufacturers will be prohibited from marketing leave-on products in Europe that contain a preservative mixture of methylchloroisothiazolinone and methylisothiazolinone under a ban the Cosmetic Ingredient Review Expert Panel anticipated with concern in recent meetings. Simultaneously, the EC announces stricter limits on propylparaben and butylparaben in personal-care items.

CIR To Present Draft Report On Infant Skin At June Meeting

Cosmetic Ingredient Review’s Infant Resource Document provides the organization’s perspective on neonatal and infant skin and chemical absorption risks to guide the CIR Expert Panel’s future reviews and development of related reports. Generally, the group believes the stratum corneum is an effective barrier in infants at or around birth, but infants’ ability to metabolize chemicals versus that of adults is not as well understood, according to the draft document, which the panel will review at its meeting in June.

Related Content

UsernamePublicRestriction

Register

RS017987

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel